GPT and Hepatic fibrosis: Considering that serum ASV concentrations were correlated with laboratory parameters including serum M2BPGi levels at 4 weeks of the therapy which may reflect the extent of liver fibrosis, serum AST and ALT levels and liver function must be carefully monitored, especially in patients with progressive liver fibrosis.